Ng, Cheng Han
4588  Ergebnisse:
Personensuche X
?
1

NASH is the Leading Cause of Hepatocellular Carcinoma in Li..:

Koh, Jia Hong ; Ng, Cheng Han ; Nah, Benjamin...
Clinical Gastroenterology and Hepatology.  22 (2024)  1 - p. 197-199.e3 , 2024
 
?
3

Upper limit of normal ALT levels in health and metabolic di..:

Tan, Eunice X. ; Huang, Daniel Q. ; Yee, Natasha Tang Sook...
Alimentary Pharmacology & Therapeutics.  59 (2024)  8 - p. 984-992 , 2024
 
?
7

Meta‐analysis: Prevalence and impact of alcohol abstinence ..:

Lim, Wen Hui ; Tay, Phoebe ; Ng, Cheng Han...
Alimentary Pharmacology & Therapeutics.  59 (2024)  6 - p. 730-741 , 2024
 
?
11

Meta‐analysis: Chemoprevention of hepatocellular carcinoma ..:

Zeng, Rebecca W. ; Yong, Jie Ning ; Tan, Darren J. H....
Alimentary Pharmacology & Therapeutics.  57 (2023)  6 - p. 600-609 , 2023
 
?
12

Higher mortality in acute coronary syndrome patients withou..:

Kong, Gwyneth ; Chin, Yip Han ; Chong, Bryan...
International Journal of Cardiology.  371 (2023)  - p. 432-440 , 2023
 
?
13

Global incidence and prevalence of nonalcoholic fatty liver..:

Teng, Margaret LP ; Ng, Cheng Han ; Huang, Daniel Q....
Clinical and Molecular Hepatology.  29 (2023)  Suppl - p. S32-S42 , 2023
 
?
15

Meta‐analysis: Prevalence of significant or advanced fibros..:

Huang, Daniel Q. ; Chan, Kai En ; Tan, Caitlyn...
Alimentary Pharmacology & Therapeutics.  58 (2023)  2 - p. 152-158 , 2023
 
1-15